The effects of probiotic bacteria on glycaemic control in overweight men and women: A randomised controlled trial

European Journal of Clinical Nutrition

Volumn 68, Issue 4, 2014, Pages 447-452

  Ivey, K L ^a,b   Hodgson, J M ^a   Kerr, D A ^c   Lewis, J R ^a,b   Thompson, P L ^b   Prince, R L ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c CURTIN UNIVERSITY   (Australia)

Author keywords

Blood glucose; Dairy products; Insulin resistance; Probiotics; Yoghurt

Indexed keywords

HEMOGLOBIN A1C; PROBIOTIC AGENT; YOGHURT; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; HEMOGLOBIN; INSULIN;

AGED; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM ANIMALIS; BODY MASS; CALORIC INTAKE; COLONY FORMING UNIT; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LACTOBACILLUS ACIDOPHILUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRIENT CONTENT; OBESITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; WAIST CIRCUMFERENCE; BACILLUS; BLOOD; DIABETES MELLITUS, TYPE 2; DIET SUPPLEMENTATION; INTERVENTION STUDY; METABOLISM; MICROBIOLOGY; MIDDLE AGED;

AGED; BACILLUS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HEMOGLOBINS; HUMANS; INSULIN; INSULIN RESISTANCE; INTERVENTION STUDIES; LACTOBACILLUS ACIDOPHILUS; MALE; MIDDLE AGED; OVERWEIGHT; PATIENT COMPLIANCE; PROBIOTICS; YOGURT;

EID: 84898015054     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2013.294     Document Type: Article

References (56)

1. Pettitt D, Lisse J, Knowler W, Bennett P. Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians. The Lancet 1980; 316: 1050-1052.
2. Laakso M, Kuusisto J. Epidemiological evidence for the association of hyperglycaemia and atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Ann Med 1996; 28: 415-418.
3. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994; 43: 960-967.
4. Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000; 321: 405-412.
5. Balkau B, Shipley M, Jarrett RJ, Pyörä lä K, Pyörälä M, Forhan A et al. High blood glucose concentration is a risk factor for mortality in middle-Aged nondiabetic men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 1998; 21: 360-367.
6. Alberti KGMM Zimmet P, Shaw J. International Diabetes Federation: A consensus on type 2 diabetes prevention. Diabet Med 2007; 24: 451-463.
7. Drucker DJ, Nauck MA. The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. The Lancet 368: 1696-705.
8. Rains JL, Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 2011; 50: 567-575.
9. Kolb H, Mandrup-Poulsen T. The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia 2010; 53: 10-20.
10. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005; 307: 1915-1920.
11. Larsen N, Vogensen FK, Van den Berg FWJ, Nielsen DS, Andreasen AS, Pedersen BK et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010; 5: E9085.
12. Furet J-P, Kong L-C, Tap J, Poitou C, Basdevant A, Bouillot J-L et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: Links with metabolic and low-grade inflammation markers. Diabetes 2010; 59: 3049-3057.
13. Ding S, Chi MM, Scull BP, Rigby R, Schwerbrock NMJ, Magness S et al. High-fat diet: Bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 2010; 5: E12191.
14. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S et al. Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science 2010; 328: 228-231.
15. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-Associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1131.
16. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004; 101: 15718-15723.
17. Yamanaka M, Nomura T, Kametaka M. Influence of intestinal microbes on heat production in germ-free, gnotobiotic and conventional mice. J Nutr Sci Vitaminol 1977; 23: 221.
18. Lye H, Kuan C, Ewe J, Fung W, Liong M. The improvement of hypertension by probiotics: Effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci 2009; 10: 3755-3775.
19. Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Argentina 2001.
20. Marteau PR, Md Vrese, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 2001; 73: 430S-436S
21. Bertolami MC, Faludi AA, Batlouni M. Evaluation of the effects of a new fermented milk product (Gaio) on primary hypercholesterolemia. Eur J Clin Nutr 1999; 53: 97.
22. Schaafsma G, Meuling WJ, Van Dokkum W, Bouley C. Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. Eur J Clin Nutr 1998; 52: 436.
23. Ataie-Jafari A, Larijani B, Alavi Majd H, Tahbaz F. Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects. Ann Nutr Metab 2009; 54: 22-27.
24. Agerbaek M, Gerdes LU, Richelsen B. Hypocholesterolaemic effect of a new fermented milk product in healthy middle-Aged men. Eur J Clin Nutr 1995; 49: 346-352.
25. Laitinen K, Poussa T, Isolauri E. Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: A randomised controlled trial. Br J Nutr 2009; 101: 1679-1687.
26. Yadav H, Jain S, Sinha PR. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 2007; 23: 62-68.
27. Tabuchi M, Ozaki M, Tamura A, Yamada N, Ishida T, Hosoda M et al. Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 2003; 67: 1421-1424.
28. Yamano T, Tanida M, Niijima A, Maeda K, Okumura N, Fukushima Y et al. Effects of the probiotic strain Lactobacillus johnsonii strain La1 on autonomic nerves and blood glucose in rats. Life Sci 2006; 79: 1963-1967.
29. Ljungberg M, Korpela R, Ilonen J, Ludvigsson J, Vaarala O. Probiotics for the prevention of beta cell autoimmunity in children at genetic risk of type 1 diabetes-The PRODIA study. Ann N Y Acad Sci 2006; 1079: 360-364.
30. Matsuzaki T, Yamazaki R, Hashimoto S, Yokokura T. Antidiabetic effects of an oral administartion of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice. Endocr J 1997; 44: 357-365.
31. Iyer C, Kosters A, Sethi G, Kunnumakkara AB, Aggarwal BB, Versalovic J. Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia- derived cells by modulation of NF-kB and MAPK signalling. Cell Microbiol 2008; 10: 1442-1452.
32. Calcinaro F, Dionisi S, Marinaro M, Candeloro P, Bonato V, Marzotti S et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 2005; 48: 1565-1575.
33. Thomas CM, Versalovic J. Probiotics-host communication: Modulation of signaling pathways in the intestine. Gut Microbes 2010; 1: 148-163.
34. Hodge A, Patterson AJ, Brown WJ, Ireland P, Giles G. The Anti Cancer Council of Victoria FFQ: Relative validity of nutrient intakes compared with weighed food records in young to middle-Aged women in a study of iron supplementation. Aust N Z Public Health 2000; 24: 576-583.
35. Ireland P, Jolley D, Giles G, O'Dea K, Powles J, Ritishauser I et al. Development of the Melbourne FFQ: A food frequency questionnaire for use in an Australian prospective study involving an ethnically diverse cohort. Asia Pac J Clin Nutr 1994; 3: 19-31.
36. Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 2002; 76: 5-56.
37. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exer 2003; 35: 1381-1395.
38. World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Geneva (Switzerland) 2011.
39. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homoeostasis model assessment: Insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
40. Montgomery A, Peters T, Little P. Design, analysis and presentation of factorial randomised controlled trials. BMC Medical Research Methodology 2003; 3: 26.
41. Bukowska H, Pieczul-Mroá z J, Jastrzebska M, Chestowski K, Naruszewicz M. Decrease in fibrinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol. Atherosclerosis 1998; 137: 437-438.
42. Naruszewicz M, Johansson M-L, Zapolska-Downar D, Bukowska H. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr 2002; 76: 1249-1255.
43. Sanggaard K, Holst J, Rehfeld J, Sandstrom B, Raben A, Tholstrup T. Different effects of whole milk and a fermented milk with the same fat and lactose content on gastric emptying and postprandial lipaemia, but not on glycaemic response and appetite. Br J Nutr 2004; 92: 447-459.
44. Shenderov BA. Metabiotics: Novel idea or natural development of probiotic conception. Microb Ecol Health Dis 2013; 24.
45. Savard P, Lamarche B, Paradis M-E, Thiboutot H, Laurin Eá, Roy D. Impact of Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus acidophilus LA-5-containing yoghurt on fecal bacterial counts of healthy adults. Int J Food Microbiol 2011; 149: 50-57.
46. Sonnenburg JL, Chen CTL, Genomic Gordon JI. Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol 2006; 4: E413.
47. Louis P, Scott KP, Duncan SH, Flint HJ. Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol 2007; 102: 1197-1208.
48. Bell A, Bauman D. Adaptations of glucose metabolism during pregnancy and lactation. J Mammary Gland Biol Neoplasia 1997; 2: 265-278.
49. Bauman DE, Bruce Currie W. Partitioning of nutrients during pregnancy and lactation: A review of mechanisms involving homoeostasis and homeorhesis. J Dairy Sci 1980; 63: 1514-1529.
50. Kalkhoff R, Kissebah A, Kim H. Carbohydrate and lipid metabolism during normal pregnancy: Relationship to gestational hormone action. Semin Perinatol 1978; 2: 291-307.
51. Lye HS, Rusul G, Liong MT. Removal of cholesterol by lactobacilli via incorporation and conversion to coprostanol. J Dairy Sci 2010; 93: 1383-1392.
52. Alander M, MättöJ, Kneifel W, Johansson M, Kögler B, Crittenden R et al. Effect of galacto-oligosaccharide supplementation on human faecal microflora and on survival and persistence of Bifidobacterium lactis Bb-12 in the gastrointestinal tract. Int Dairy J 2001; 11: 817-825.
53. Fukushima Y, Kawata Y, Hara H, Terada A, Mitsuoka T. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 1998; 42: 39-44.
54. Savard P, Lamarche B, Paradis M-E, Thiboutot H, Laurin Eá, Roy D. Impact of Bifidobacterium animalis subsp.lactis BB-12 and Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults. Int J Food Microbiol 2011; 149: 50-57.
55. Schillinger U, Guigas C, Heinrich Holzapfel W. In vitro adherence and other properties of lactobacilli used in probiotic yoghurt-like products. Int Dairy J 2005; 15: 1289-1297.
56. Collado MC, Jalonen L, Meriluoto J, Salminen S. Protection mechanism of probiotic combination against human pathogens: In vitro adhesion to human intestinal mucus. Asia Pac J Clin Nutr 2006; 15: 570-575.